UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 29, 2024 Scorpius Holdings, Inc. (Exact name of registrant as specified in charter) Delaware 001-35994 26-2844103 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 627 Davis Drive, Suite 300 Morrisville, North Carolina 27560 (Address o ...

财务状况 - 公司截至2024年5月17日拥有约5.6百万美元的现金及现金等价物和短期投资，需要产生大量收入才能实现盈利，但可能永远无法实现[171] - 公司管理层认为公司在财务报表发布后一年内持续经营的能力存在重大疑虑[171] - 公司截至2024年3月31日累计亏损2.588亿美元，预计将产生大量与Scorpius制造设施相关的商业化费用[176] 融资计划 - 公司计划通过多种方式满足设施运营的融资需求,包括现金、补助金和激励、额外股权融资、债务融资、设备销售租回以及CDMO生产设施带来的额外收入[141] - 公司于2024年5月完成公开发行,共发行29,820,000个单位和30,180,000个预付款单位,募集资金总额约600万美元[142] - 公司拟将公开发行所得款项用于营运资金、一般公司用途以及偿还一笔750,000美元的关联方非可转换承兑票据[143] - 公司于2024年5月从关联方Elusys Holdings Inc.获得750,000美元贷款,并发行了一张2,250,000美元的经修订的可转换承兑票据[145] - 公司于2024年3月完成了1,235,000美元的公开发行[146] - 公司需要尽快或更多地获得额外资金，潜在的融资来源包括战略合作伙伴、公开或私募股权或债务融资、兼并、出售公司、资产剥离等[170] - 公司可能无法在需要时以可接受的条款获得额外资金，如果无法筹集到资金可能需要推迟、减少或终止部分或全部业务运营，并可能被迫停止运营、清算资产并寻求破产保护[170] 运营情况 - 公司于2022年9月开始运营位于圣安东尼奥的租赁设施[140] - 公司2024年第一季度实现3.5百万美元的工艺开发收入,较2023年同期增长[155] - 公司2024年第一季度研发支出为3.9百万美元,较2023年同期下降[158][159] - 2024年第一季度经营活动使用的现金主要由于净亏损调整非现金支出和营运资金变动所致，较2023年同期减少9.1百万美元[172] - 2024年第一季度投资活动提供的现金较2023年同期减少10.7百万美元,主要由于出售短期投资净额减少13.0百万美元[173] - 2024年第一季度筹资活动提供的现金较2023年同期增加3.6百万美元,主要来自公开发行股票净收益1.2百万美元和发行可转换债券2.3百万美元[174] 其他 - 公司于2024年1月以100万美元的价格出售了与Shattuck Labs, Inc.的独家许可协议[147] - 公司于2024年1月将1,000,000美元的承兑票据出售给关联方Elusys Holdings[148] - 公司为小型报告公司,无需提供市场风险的定量和定性披露[177]

| | | UNITED | | | |--------------|-----------------------------------------------------------------|--------------------------------------------------------|-----------------------------------------------------|----------------------------------------| | | | SECURITIES AND | COMMISSION | | | | | Washington, | | | | | | FORM | | | | ☑ | ANNUAL REPORT PURSUANT TO | SECTION 13 OR 15(d) OF | SECURITIES EXCHANGE ACT | OF 1934 | | | | For the fiscal year ended | 31, 2023 | | | | | OR | | | | ☐ | TRANSITION REPOR ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 7, 2024 Scorpius Holdings, Inc. (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-35994 26-2844103 (Commission File Number) (IRS Employer Identification No.) 627 Davis Drive, Suite 400 Morrisville, North Carolina 27560 (Address ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-35994 | NightHawk | |-----------------------------------------| | (Exact name of registrant ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-35994 | NightHawk | |-----------------------------------------| | (Exact name of registrant as | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-35994 NightHawk Biosciences, Inc. (Exact name of registrant as specified in its charter) Delawa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-35994 NightHawk Biosciences, Inc. (Exact name of registrant as specified in its charter) Delaware 26-2844103 (State or other jur ...